title: Inhibitory effect of fibronectin and its recombinant polypeptides on the adhesion of metastatic melanoma cells to laminin.
abstract: We have utilized recombinant fibronectin fragments with cell-binding domain (C-274), heparin-binding domain (H-271) or CS1 peptide in type III connecting segment (IIICS) and their fusion polypeptides such as CH-296 (containing C-274, H-271 and CS1), CH-271 (containing C-274 and H-271) and C-CS1 (containing C-274 and CS1) to investigate the mechanism of the fibronectin-mediated inhibitory effect on tumor cell adhesion to laminin as well as fibronectin. These fragments retained cell adhesion-promoting and/or heparin-binding properties when they were immobilized on a surface. Pretreatment of tumor cells with CH-296 or CH-271 suppressed cell adhesion to both laminin and fibronectin. H-271 at the high concentration of 500 micrograms/ml slightly inhibited cell adhesion to laminin (but not to fibronectin), whereas C-274, C-CS1 or a mixture of C-274, H-271 and CS1 (similar molar ratio to CH-296) inhibited cell adhesion to fibronectin but not to laminin. On the other hand, tumor cell adhesion to laminin-substrate was also inhibited by heparin or heparan sulfate, which were able to bind to laminin, suggesting that heparin-like molecules on the cell surface may be included among the laminin receptors. These results indicated that the co-presence of cell- and heparin-binding domains of fibronectin may be required for the fibronectin-mediated inhibitory effect on tumor cell adhesion to laminin, and that the interaction of the heparin-binding domain of fibronectin with the cell surface leads to the inhibition of the cell adhesion to laminin.
authors.affiliation: Institute of Immunological Science, Hokkaido University, Sapporo.
authors.forename: I
authors.initials: I
authors.lastname: Saiki
authors.forename: T
authors.initials: T
authors.lastname: Makabe
authors.forename: J
authors.initials: J
authors.lastname: Yoneda
authors.forename: J
authors.initials: J
authors.lastname: Murata
authors.forename: Y
authors.initials: Y
authors.lastname: Ishizaki
authors.forename: F
authors.initials: F
authors.lastname: Kimizuka
authors.forename: I
authors.initials: I
authors.lastname: Kato
authors.forename: I
authors.initials: I
authors.lastname: Azuma
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D002448:Cell Adhesion; D005353:Fibronectins / Q000737:chemistry / Q000378:metabolism*; D006493:Heparin / Q000494:pharmacology; D007797:Laminin / Q000378:metabolism*; D008546:Melanoma, Experimental / Q000473:pathology*; D051379:Mice; D008969:Molecular Sequence Data; D010455:Peptides / Q000378:metabolism; D011485:Protein Binding; D011994:Recombinant Proteins / Q000378:metabolism; D013329:Structure-Activity Relationship; D014407:Tumor Cells, Cultured
chemical_list: D005353:Fibronectins; D007797:Laminin; D010455:Peptides; D011994:Recombinant Proteins; D006493:Heparin